The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.The three major stock indexes opened lower, with the Shanghai Composite Index down 0.19%, the Shenzhen Component Index down 0.29% and the Growth Enterprise Market down 0.15%.Wei Shaojun, China Semiconductor Industry Association: We should vigorously develop chip design technology that does not depend on advanced technology. Wei Shaojun, chairman of the Integrated Circuit Design Branch of China Semiconductor Industry Association, said today that with the closure of chip design enterprises in China by external advanced processing resources, the manufacturing technologies that can be used by chip design enterprises in China are no longer as rich as before, and it is necessary to pay attention to the design technology that does not depend on advanced technology in technological innovation. Among them, there are two technical paths worth exploring. One is the innovation of architecture, which has been suggested by the industry that it is the golden age of computer architecture innovation. The second is micro-system integration, and the three-dimensional integration technology evolved from packaging technology is gradually moving towards the foreground. (Reporter Guo Hui)
Six countries' chemical companies set up resource recycling companies, including new material technology research and development business. According to the enterprise survey APP, Hubei Xingyang Resource Recycling Co., Ltd. was recently established, with the legal representative of Xu Jinchong and the registered capital of about 145 million yuan. Its business scope includes: new material technology research and development; Manufacturing of eco-environmental materials; Sales of eco-environmental materials; Lime and gypsum manufacturing; Manufacturing of light building materials; Environmental consulting services; Processing of renewable resources, etc. Enterprise equity penetration shows that the company is jointly owned by Hubei Huiyang New Materials Co., Ltd. and dangyang city Jiantou Asset Management Co., Ltd., a subsidiary of Liuguo Chemical.Trump announced a number of latest nominations, including the Deputy Secretary of State. On December 10, local time, US President-elect Trump announced a number of latest nominations on his social media platform. Trump announced the nomination of Ed Martin as the next chief of staff of the White House Office of Management and Budget, Dan Bishop, a congressman from North Carolina, as the deputy director of the budget of the White House Office of Management and Budget, and Jacob Helberg as the next deputy secretary of state responsible for economic growth, energy and environment. Nominate Mark Meador as a member of the US Federal Trade Commission, Kimberly Guilfoyle as the next US ambassador to Greece, and Tom Barrack as the next US ambassador to Turkey.In early trading, most of the main contracts of domestic futures fell. Palm oil fell more than 2%, alumina, Shanghai nickel, coking coal, glass, iron ore, soda ash and lithium carbonate fell more than 1%, and No.20 glue, methanol and stainless steel (SS) fell nearly 1%. In terms of increase, the Shanghai-Tianjin and Container Lines Europe rose by over 1%, while vegetable oil and fuel oil rose by nearly 1%.
Shanghai's state-owned assets reform concept stocks rose to the daily limit, and Shanghai Material Trade, First Medicine, Shibei High-tech, Kaikai Industry and Shanghai 900 set an international daily limit.Shandong mining machine opened at a daily limit, and yesterday it staged the "Earth-Sky Board".Lee Ka Chiu John: The Hong Kong SAR Government hopes to set up a food and drug administration in the future. Lee Ka Chiu John, Chief Executive of the Hong Kong Special Administrative Region (HKSAR) said today (11th) that the SAR Government hopes to set up a food and drug administration in the long run to give full play to the advantages of clinical trials with the Mainland.
Strategy guide
12-14
Strategy guide